Editor's Corner

Just a quick reminder: We'll be doing an hour-long webinar tomorrow at 2 EST covering biodefense and infectious disease research in Maryland. The webinar also covers some of the incentives the state has on offer. Be sure to register and join us. - John Carroll

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.